Nationwide representative serosurvey of third-grade school children to evaluate the hepatitis B vaccination impact in Kyrgyzstan, 2022
Our study demonstrates the impact of a successfully implemented hepatitis B vaccination programme in Kyrgyzstan. High hepatitis B vaccination coverage has resulted in very low HBsAg seroprevalence among vaccinated birth cohorts, paving the way towards the achievement of regional hepatitis B control targets. Maintaining high vaccination uptake plus additional measures like screening of pregnant women and treatment of those infected will be key to achieve elimination of vertical transmission of hepatitis B in Kyrgyzstan.
Authors
- Gulbara Ishenapysova (ORCID: https://orcid.org/0000-0003-1356-6321)
- Tatiana Enverovna Kuchuk
- Michael Brandl (ORCID: https://orcid.org/0000-0003-2820-5019)
- Martyna Gassowski
- Siddhartha Sankar Datta (ORCID: https://orcid.org/0000-0002-9829-3248)
- Sandra Dudareva (ORCID: https://orcid.org/0000-0003-1803-704X)
- Z. I. Bekenova
- Gulsunai J. Sattarova (ORCID: https://orcid.org/0000-0003-4530-7594)
- Liudmila Mosina (ORCID: https://orcid.org/0000-0003-2824-6267)
- Antons Mozalevskis (ORCID: https://orcid.org/0000-0003-2275-5909)
- Zuridin Nurmatov
- Saikal N. Temirbekova
- Gulnara Zh. Zhumagulova
- Nurzhan Zamirbekova
Institutions
- Robert Koch Institute (DE)
- Humboldt-Universität zu Berlin (DE)
- World Health Organization Regional Office for Europe (DK)
- World Health Organization (CH)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1186/s12879-025-10491-8
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Australian Government
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- Robert Koch Institut